Dengju相关文献与解析，生知库 | 链接生命科学的每一步

Deng, Xinyue; Gao, Qiang; Shen, Kefeng; Mu, Wei; Ge, Tong; Gu, Jia; Yang, Xiuxiu; Cheng, Jiali; Wang, Jiachen; Zhang, Wei; Li, Dengju; Zhou, Jianfeng; Xiao, Min

发表日期：2026

文献求助收藏

Correction to: Significance of targeting DNMT3A mutations in AML

更正：靶向 DNMT3A 突变在急性髓系白血病中的意义

期刊:Annals of Hematology

影响因子:2.4

doi:10.1007/s00277-026-06929-x

Huang, Guiqin; Cai, Xiaoya; Li, Dengju

Improving CAR-T cell function through a targeted cytokine delivery system utilizing car target-modified extracellular vesicles.

利用靶向修饰的细胞外囊泡，通过靶向细胞因子递送系统改善 CAR-T 细胞功能

期刊:Experimental Hematology & Oncology

影响因子:13.5

doi:10.1186/s40164-025-00701-z

Zhang Yuanyuan, Huang Meijuan, Zhang Shujia, Liu Tianjiao, Ye Shanwei, Cheng Yuhang, Cao Yang, Chen Liting, Zhu Li, Sun Xueyan, Shen Kefeng, Xu Qian, Li Tongjuan, Li Dengju, Huang Liang, Mu Wei, Zhao Lei, Wang Jue

Dasatinib-resistant universal CAR-T cells proliferate in the presence of host immune cells and exhibit antitumor activity

达沙替尼耐药的通用型CAR-T细胞在宿主免疫细胞存在的情况下增殖并表现出抗肿瘤活性。

期刊:Molecular Therapy

影响因子:12

doi:10.1016/j.ymthe.2025.02.012

Cheng, Yuhang; Zhang, Jiayuan; Mu, Wei; Ye, Shanwei; Cheng, Jiali; Zhu, Li; Wang, Gaoxiang; Cao, Yang; Li, Dengju; Hu, Guang; Huang, Liang; Wang, Jue; Zhou, Jianfeng

CD5 ablation enhances persistence and antitumor potency of engineered T cells by mitigating exhaustion and promoting cytotoxicity

CD5 清除通过减轻 T 细胞耗竭和促进细胞毒性，增强工程化 T 细胞的持久性和抗肿瘤效力。

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.6

doi:10.1136/jitc-2025-012243

Wu, Jia; Cheng, Jiali; Zhu, Li; Gao, Qiang; Lin, Haolong; Zeng, Yuhao; Li, Yong; Li, Weini; An, Ning; Huang, Liang; Xiao, Min; Li, Dengju; Mu, Wei

Efficacy and safety of a novel CD19, CD22 dual-targeted fully human loop bi-CAR-T for the treatment of relapsed/refractory B cell non-Hodgkin lymphoma

一种新型CD19、CD22双靶向全人源环状双CAR-T细胞疗法治疗复发/难治性B细胞非霍奇金淋巴瘤的疗效和安全性

期刊:Journal of Translational Medicine

影响因子:7.5

doi:10.1186/s12967-025-06567-3

Wang, Hanyu; Wang, Gaoxiang; Li, Tongjuan; Zhang, Peiling; Mao, Zekai; Luo, Hui; Zhu, Xiaojian; Li, Dengju; Zhou, Jianfeng; Zhou, Xiaoxi; Huang, Liang

Bridging transplantation and immunotherapy: Clinical promise of autologous stem cell transplantation with chimeric antigen receptor T-cell therapy

移植与免疫疗法的桥梁：自体干细胞移植联合嵌合抗原受体T细胞疗法的临床前景

期刊:Chinese Journal of Cancer Research

影响因子:6.3

doi:10.21147/j.issn.1000-9604.2025.04.03

Yan, Yixin; Dai, Zigang; Li, Dengju; Mao, Xia; Huang, Liang

Next-generation T cell immunotherapy: overcoming exhaustion, senescence, and suppression

下一代T细胞免疫疗法：克服耗竭、衰老和抑制

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2025.1662145

Li, Guangmei; Li, Dengju; Zhu, Xiaojian

Prediction of the Association between Transfer RNA and Diseases: A Deep Learning Approach Combining Multi-View Graph Convolution and Attention Mechanisms

预测转移RNA与疾病之间的关联：一种结合多视图图卷积和注意力机制的深度学习方法

期刊:ACS Omega

影响因子:4.3

doi:10.1021/acsomega.5c03029

Li, Xiangkui; Yao, Dengju; Zhang, Bo; Zhan, Xiaojuan; Zhang, Jian

发表日期：2025

文献求助收藏

Indirect Comparisons of Efficacy of Zanubrutinib Versus Orelabrutinib in Patients with R/R MCL: An Extended Follow-up Analysis

泽布替尼与奥瑞替尼治疗复发/难治性套细胞淋巴瘤患者疗效的间接比较：一项扩展随访分析

期刊:Advances in Therapy

影响因子:4

doi:10.1007/s12325-025-03202-x

Deng, Lijuan; Song, Yuqin; Zhou, Keshu; Li, Dengju; Hu, Jianda; Zou, Dehui; Gao, Sujun; Yang, Haiyan; Zhang, Huilai; Ji, Jie; Xu, Wei; Feng, Ru; Jin, Jie; Lv, Fangfang; Fang, Cheng; Xu, Sheng; Zhu, Jun

TNFRSF13B Variant-Induced TACI Dysregulation Underlies CAEBV Pathogenesis

TNFRSF13B 变异诱导的 TACI 失调是 CAEBV 发病机制的基础

Correction to: Significance of targeting DNMT3A mutations in AML

更正：靶向 DNMT3A 突变在急性髓系白血病中的意义

Improving CAR-T cell function through a targeted cytokine delivery system utilizing car target-modified extracellular vesicles.

利用靶向修饰的细胞外囊泡，通过靶向细胞因子递送系统改善 CAR-T 细胞功能

Dasatinib-resistant universal CAR-T cells proliferate in the presence of host immune cells and exhibit antitumor activity

达沙替尼耐药的通用型CAR-T细胞在宿主免疫细胞存在的情况下增殖并表现出抗肿瘤活性。

CD5 ablation enhances persistence and antitumor potency of engineered T cells by mitigating exhaustion and promoting cytotoxicity

CD5 清除通过减轻 T 细胞耗竭和促进细胞毒性，增强工程化 T 细胞的持久性和抗肿瘤效力。

Efficacy and safety of a novel CD19, CD22 dual-targeted fully human loop bi-CAR-T for the treatment of relapsed/refractory B cell non-Hodgkin lymphoma

一种新型CD19、CD22双靶向全人源环状双CAR-T细胞疗法治疗复发/难治性B细胞非霍奇金淋巴瘤的疗效和安全性

Bridging transplantation and immunotherapy: Clinical promise of autologous stem cell transplantation with chimeric antigen receptor T-cell therapy

移植与免疫疗法的桥梁：自体干细胞移植联合嵌合抗原受体T细胞疗法的临床前景

Next-generation T cell immunotherapy: overcoming exhaustion, senescence, and suppression

下一代T细胞免疫疗法：克服耗竭、衰老和抑制

Prediction of the Association between Transfer RNA and Diseases: A Deep Learning Approach Combining Multi-View Graph Convolution and Attention Mechanisms

预测转移RNA与疾病之间的关联：一种结合多视图图卷积和注意力机制的深度学习方法

Indirect Comparisons of Efficacy of Zanubrutinib Versus Orelabrutinib in Patients with R/R MCL: An Extended Follow-up Analysis

泽布替尼与奥瑞替尼治疗复发/难治性套细胞淋巴瘤患者疗效的间接比较：一项扩展随访分析